|
|
 |
|
Viewing report
|
|
 |
Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market
GlobalData, Feb 2011, Pages: 5
Strong Pipeline Characterized with Novel Therapies will Drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market
Summary
Our report, “Strong Pipeline Characterized with Novel Therapies will drive the Methicillin-Resistant Staphylococcus Aureus (MRSA) Market” provides key information on current available treatment of MRSA and how the novel pipeline molecules will drive the global market of MRSA.
Scope
- Data and information on noval therapy on MRSA market
Reasons to buy
- Develop business strategies by understanding the trends and developments in MRSA Market
|
 |
|
|